CORCEPT THERAPEUTICS INC (CORT) › Operating IncomeCORCEPT THERAPEUTICS INC (CORT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$20.25M2010: -$27.44M2011: -$32.33M2012: -$36.27M2013: -$41.50M2014: -$27.62M2015: -$3.44M2016: $10.18M2017: $52.85M2018: $89.50M2019: $111.61M2020: $128.20M2021: $124.48M2022: $112.63M2023: $107.28M2024: $136.95M2025: $44.80M$44.80M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$44.80M-67.3%2024$136.95M+27.7%2023$107.28M-4.8%2022$112.63M-9.5%2021$124.48M-2.9%2020$128.20M+14.9%2019$111.61M+24.7%2018$89.50M+69.3%2017$52.85M+419.3%2016$10.18M+395.6%2015-$3.44M+87.5%2014-$27.62M+33.4%2013-$41.50M-14.4%2012-$36.27M-12.2%2011-$32.33M-17.8%2010-$27.44M-35.5%2009-$20.25M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share